SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-010936
Filing Date
2022-11-01
Accepted
2022-11-01 16:12:36
Documents
1
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 form4-11012022_011127.html 4  
1 form4-11012022_011127.xml 4 4073
  Complete submission text file 0001415889-22-010936.txt   5425
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALA PHARMACEUTICALS, INC. 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address
Farid Marjan (Reporting) CIK: 0001952098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 221350363